Ingalls & Snyder’s ImmuCell ICCC Stock Holding History
Bought
Maintained
Sold
Other funds holding ICCC
PCM
Ingalls & Snyder's ICCC Position: Q1 2021 in Review
Ingalls & Snyder sold out of ImmuCell (ICCC) in Q1 2021, closing a stake of 10,000 shares — an estimated $60K sold.
Ingalls & Snyder first reported a position in ICCC in Q3 2018 and held it in 10 quarters. The position peaked at $762K in Q3 2018. 28 funds tracked by Wall St. Rank hold ICCC as of Q1 2021.
- Ingalls & Snyder reported no remaining ImmuCell position as of Q1 2021 after selling out during the quarter.
- Ingalls & Snyder sold 10,000 ImmuCell shares in Q1 2021, an estimated $60K.
- Ingalls & Snyder first reported a position in ImmuCell in Q3 2018 and held it in 10 quarters.
- Ingalls & Snyder's ImmuCell position peaked at $762K in Q3 2018.
- 28 funds tracked by Wall St. Rank held ImmuCell as of Q1 2021.
Based on Ingalls & Snyder's 13F filing for Q1 2021, filed 21 Apr 2021.